These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8028387)

  • 1. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study.
    Daily PO; Lamphere JA; Dembitsky WP; Adamson RM; Dans NF
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):99-106; discussion 106-8. PubMed ID: 8028387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery.
    Kikura M; Levy JH; Tanaka KA; Ramsay JG
    J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilon-aminocaproic acid in coronary artery bypass graft surgery: preincision or postheparin?
    Kluger R; Olive DJ; Stewart AB; Blyth CM
    Anesthesiology; 2003 Dec; 99(6):1263-9. PubMed ID: 14639137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting.
    Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML
    Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin.
    Greilich PE; Brouse CF; Whitten CW; Chi L; Dimaio JM; Jessen ME
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1498-503. PubMed ID: 14666025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization.
    Hardy JF; Bélisle S; Dupont C; Harel F; Robitaille D; Roy M; Gagnon L
    Ann Thorac Surg; 1998 Feb; 65(2):371-6. PubMed ID: 9485231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial.
    Verma K; Errico T; Diefenbach C; Hoelscher C; Peters A; Dryer J; Huncke T; Boenigk K; Lonner BS
    J Bone Joint Surg Am; 2014 May; 96(10):e80. PubMed ID: 24875032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
    Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
    Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blinded trial comparing the effectiveness of tranexamic acid and epsilon-aminocaproic acid in reducing bleeding and transfusion in cardiac surgery.
    Leff J; Rhee A; Nair S; Lazar D; Sathyanarayana SK; Shore-Lesserson L
    Ann Card Anaesth; 2019; 22(3):265-272. PubMed ID: 31274487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid.
    Greilich PE; Okada K; Latham P; Kumar RR; Jessen ME
    Circulation; 2001 Sep; 104(12 Suppl 1):I265-9. PubMed ID: 11568067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass.
    Gurian DB; Meneghini A; Abreu LC; Murad N; Matos LL; Pires AC; Valenti VE; Breda JR
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):615-20. PubMed ID: 23434921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
    Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
    J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose epsilon-aminocaproic acid versus aprotinin: antifibrinolytic efficacy in first-time coronary operations.
    Eberle B; Mayer E; Hafner G; Heinermann J; Dahm M; Prellwitz W; Dick W; Oelert H
    Ann Thorac Surg; 1998 Mar; 65(3):667-73. PubMed ID: 9527193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.
    Martin K; Gertler R; MacGuill M; Mayr NP; Hapfelmeier A; Hörer J; Vogt M; Tassani P; Wiesner G
    Br J Anaesth; 2013 Apr; 110(4):615-21. PubMed ID: 23213034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease.
    Chauhan S; Kumar BA; Rao BH; Rao MS; Dubey B; Saxena N; Venugopal P
    Ann Thorac Surg; 2000 Oct; 70(4):1308-12. PubMed ID: 11081890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost.
    Ray MJ; O'Brien MF
    Ann Thorac Surg; 2001 Mar; 71(3):838-43. PubMed ID: 11269462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.
    Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Sansano T; Rafecas A; Figueras J; Jaurrieta E; Parrilla P
    Anesth Analg; 2000 Jul; 91(1):29-34. PubMed ID: 10866882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.